1 Jan 1998 Jahr - Trastuzumab
Beschreibung:
For the treatment of women with HER2-positive metastatic breast cancer, the Food and Drug Administration (FDA) recommends trastuzumab, a monoclonal antibody that inhibits cancer cells that overproduce the HER2 protein.
Zugefügt zum Band der Zeit:
Datum: